ART_ID field
- Containing table:
- tblART
- Explanation of variable:
- represents the antiretroviral treatment
- Format of data:
- character. see coding table for valid codings.
Coding Table
A set of extended ATC codes are being presented here in order to code both more specific on subtypes of the drugs, e.g. saquinavir hard and soft gel, but also to enable coding of drugs that are at their trial stage and have not yet been assigned an ATC code. To do this the drug will be assigned the code elements as far down the levels as possible. Given two examples to illustrate this:
- Saquinavir - Hard Gel
- J05AE01-SQH
- Saquinavir - Soft Gel
- J05AE01-SQS
- Saquinavir - not specified
- J05AE01
This will ensure the fidelity needed to distinguish between hard and soft gel and not specified, but also for analysis easily include all records which coding starts with J05AE01, regardless if the drug is hard or soft gel.
See the ATC Index for the individual codes. The extended ATC codes are listed below along with a subset of ATC codes relevant to ART.
| Code (Extended ATC Codes) | Anti-Retroviral Drugs |
|---|---|
| J05A | ART unspecified |
| J05A-BEV | Bevirimat |
| J05A-PBT | Participant in Blinded Trial |
| J05AE | PI unspecified |
| J05AE-MOZ | Mozenavir (DMP-450) |
| J05AE01 | Saquinavir (gel, not specified) |
| J05AE01-SQH | Saquinavir hard gel (INVIRASE) |
| J05AE01-SQS | Saquinavir soft gel (FORTOVASE) |
| J05AE02 | Indinavir (CRIXIVAN) |
| J05AE03 | Ritonavir (NORVIR) |
| J05AE03-H | Ritonavir high dose (NORVIR) |
| J05AE03-L | Ritonavir low dose (NORVIR) |
| J05AE04 | Nelfinavir (VIRACEPT) |
| J05AE05 | Amprenavir (AGENERASE) |
| J05AE07 | Fos-amprenavir (Telzir, Lexiva) |
| J05AE08 | Atazanavir (Reyataz) |
| J05AE09 | Tipranavir (Aptivus) |
| J05AE10 | Darunavir (TMC-114, Prezista) |
| J05AF | NRTI unspecified |
| J05AF-ALO | Alovudine |
| J05AF-AMD | Amdoxovir (DADP) |
| J05AF-FOZ | Fozivudine tidoxi |
| J05AF-LDN | Lodenosine (trialdrug) |
| J05AF-RVT | Reverset |
| J05AF01 | Zidovudine (AZT, RETROVIR) |
| J05AF02 | Didanosine (ddI) (VIDEX) |
| J05AF03 | Zalcitabine (ddC) (HIVID) |
| J05AF04 | Stavudine (d4T) (ZERIT) |
| J05AF05 | Lamivudine (3TC, EPIVIR) |
| J05AF06 | Abacavir (1592U89) (ZIAGEN) |
| J05AF07 | Tenofovir (VIREAD) |
| J05AF09 | Emtricitabine |
| J05AF13 | TAF: Tenofoviralafenamid (TAF) |
| J05AG | NNRTI unspecified |
| J05AG-CPV | Capravirine |
| J05AG-DPC083 | DPC 083 |
| J05AG-DPC961 | DPC 961 |
| J05AG-EMV | Emivirine (MKC442) |
| J05AG-LOV | Loviride |
| J05AG01 | Nevirapine (VIRAMUN) |
| J05AG02 | Delavirdine (U-90152) (RESCRIPTOR) |
| J05AG03 | Efavirenz (DMP-266) (STOCRIN, SUSTIVA) |
| J05AG04 | Etravirine (TMC 125) |
| J05AG05 | Rilpivirine (TMC-278) |
| J05AG06 | Doravirine |
| J05AJ04 | Cabotegravir |
| J05AR01 | Combivir (Zidovudine/Lamivudine) |
| J05AR02 | Kivexa (Lamivudine/Abacavir) |
| J05AR03 | Truvada (Tenofovir/Emtricabine) |
| J05AR04 | Trizivir (Zidovudine/Lamivudine/Abacavir) |
| J05AR05 | Douvir-N (Zidovudine/Lamivudine/Nevirapine) |
| J05AR06 | Atripla (Emtricitabine/Tenofovir/Efavirenz) |
| J05AR07 | Triomune (Stavudine/Lamivudine/Nevirapine) |
| J05AR08 | Eviplera/Complera (Emtricitabine/Tenofovir/Rilpivirine) |
| J05AR09 | Stribild (Emtricitabine/Tenofovir/Elvitegravir/Cobicistat) |
| J05AR10 | Lopinavir/Ritonavir (Kaletra). Former code: J05AE06 |
| J05AR10 | Kaletra/Aluvia (Lopinavir/Ritonavir) |
| J05AR11 | Lamivudine, tenofovir disoproxil and efavirenz |
| J05AR12 | Lamivudine and tenofovir disoproxil |
| J05AR13 | Triumeq (Lamivudine, abacavir and dolutegravir) |
| J05AR14 | Darunavir and cobicistat |
| J05AR15 | Atazanavir and cobicistat |
| J05AR16 | Lamivudine and raltegravir |
| J05AR17 | Emtricitabine and tenofovir alafenamide |
| J05AR18 | Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat |
| J05AR19 | Emtricitabine, tenofovir alafenamide and rilpivirine |
| J05AR20 | Emtricitabine, Tenofovir Alafenamide and Bictegravir |
| J05AR21 | JLC: Juluca (DTG/RPV) |
| J05AR22 | Symtuza (Emtricitabine, Tenofovir, Alafenamide, Darunavir and Cobicistat) |
| J05AR24 | Lamivudine, Tenofovir, Disoproxil and Doravirine |
| J05AR25 | Lamivudine and Dolutegravir |
| J05AX-VIC | Vicriviroc (Schering) |
| J05AX07 | Enfuvirtide (Fuzeon, T-20) |
| J05AX08 | Raltegravir (Merck) |
| J05AX09 | Maraviroc (Pfizer) |
| J05AX11 | Elvitegravir |
| J05AX12 | Dolutegravir |
| L01XX05 | Hydroxyurea/Hydroxycarbamid (Litalir) |
| V03AX03 | Cobicistat |